Show items per page
Elements: 25
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
The degradation of semisynthetic tritiated insulin by perfused mouse livers Halban, Philippe A.; Karakash, C.; Davies, J. G.; Offord, Robin Ewart 1976
add to browser selection
Inhibition of degradation of insulin by ophthalamic acid and by a bovine pancreatic proteinase inhibitor Offord, Robin Ewart; Philippe, Jacques; Davis, J. G.; Halban, Philippe A.; Berger, M. 1979
add to browser selection
Amino acid sequence determination by gas chromatography—mass spectrometry of permethylated peptides Rose, Keith; Bairoch, Amos Marc; Offord, Robin Ewart 1983
add to browser selection
Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs Torre, V S; Marozsan, A J; Albright, J L; Collins, K R; ... Arts, E J 2000
add to browser selection
Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression Sabbe, Rebecca; Picchio, Gastón R; Pastore, Cristina; Chaloin, Olivier; ... Mosier, Donald E 2001
add to browser selection
Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTES. Pastore, Cristina; Picchio, Gastón R; Galimi, Francesco; Fish, Richard; ... Mosier, Donald E 2003
add to browser selection
Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines Hartley, Oliver; Dorgham, Karim; Perez-Bercoff, Danielle; Cerini, Fabrice; ... Gorochov, Guy 2003
add to browser selection
Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5 Lederman, Michael M; Veazey, Ronald S; Offord, Robin Ewart; Mosier, Donald E; ... Hartley, Oliver 2004
add to browser selection
PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes Kawamura, Tatsuyoshi; Bruce, Shannon E; Abraha, Awet; Sugaya, Makoto; ... Blauvelt, Andrew 2004
add to browser selection
Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors Hartley, Oliver; Gaertner, Hubert François; Wilken, Jill; Thompson, Darren; ... Offord, Robin Ewart 2004
add to browser selection
Engineering chemokines to develop optimized HIV inhibitors Hartley, Oliver; Offord, Robin Ewart 2005
add to browser selection
Microbicides and other topical strategies to prevent vaginal transmission of HIV. Lederman, Michael M; Offord, Robin Ewart; Hartley, Oliver 2006
add to browser selection
Chemokine analogues show suitable stability for development as microbicides Cerini, Fabrice; Landay, Alan; Gichinga, Carolyne; Lederman, Michael M.; ... Hartley, Oliver 2008
add to browser selection
Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide Gaertner, Hubert François; Cerini, Fabrice; Escola, Jean-Michel; Kuenzi, Gabriel; ... Hartley, Oliver 2008
add to browser selection
Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 beta/CCL4 Gaertner, Hubert François; Lebeau, Olivier; Borlat, Irène; Cerini, Fabrice; ... Hartley, Oliver 2008
add to browser selection
Semisynthetic analogues of PSC-RANTES, a potent anti-HIV protein Gaertner, Hubert François; Offord, Robin Ewart; Botti, Paolo; Kuenzi, Gabriel; Hartley, Oliver 2008
add to browser selection
Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian-human immunodeficiency virus challenge Veazey, Ronald S.; Ling, Binhua; Green, Linda C.; Ribka, Erin P.; ... Hartley, Oliver 2009
add to browser selection
"Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1 SF162 or simian-human immunodeficiency virus SHIV SF162-p3 do not confer resistance Nedellec, Rebecca; Coetzer, Mia; Lederman, Michael M.; Offord, Robin Ewart; ... Mosier, Donald E. 2010
add to browser selection
Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use Nedellec, Rebecca; Coetzer, Mia; Lederman, Michael M; Offord, Robin Ewart; ... Mosier, Donald E 2011
add to browser selection
Circulating human CD4 and CD8 T cells do not have large intracellular pools of CCR5 Pilch-Cooper, Heather A; Sieg, Scott F; Hope, Thomas J; Koons, Ann; ... Lederman, Michael M 2011
add to browser selection
CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist Activity Choi, Won-Tak; Nedellec, Rebecca; Coetzer, Mia; Colin, Philippe; ... Mosier, Donald E 2012
add to browser selection
Using glycosaminoglycan/chemokine interactions for the long-term delivery of 5P12-RANTES in HIV prevention Wang, Nick X; Sieg, Scott F; Lederman, Michael M; Offord, Robin Ewart; ... von Recum, Horst A 2013
add to browser selection
A scalable low-cost cGMP process for clinical grade production of the HIV inhibitor 5P12-RANTES in Pichia pastoris Cerini, Fabrice; Gaertner, Hubert François; Madden, Knut; Tolstorukov, Ilya; ... Hartley, Oliver 2016
add to browser selection
Pharmacokinetics of the Protein Microbicide 5P12-RANTES in Sheep following Single-Dose Vaginal Gel Administration McBride, John W; Dias, Nicola; Cameron, David; Offord, Robin Ewart; ... Malcolm, R Karl 2017
add to browser selection
Stability of 5P12-RANTES, A Candidate Rectal Microbicide, in Human Rectal Lavage Cerini, Fabrice; Offord, Robin Ewart; McGowan, Ian; Hartley, Oliver 2017